9-ING-41, a Small Molecule Inhibitor of GSK-3β, Potentiates the Effects of Chemotherapy on Colorectal Cancer Cells.

Front Pharmacol · 2021 · PMC8696016 · PMID 34955846

Europe PMC DOI

hedged sentence

0.1400

closest p · 2.8× alpha

0.1400

boldest claim

The sentences

did not reach statistical significancep = .14not close (p > 0.1)

In the case of combination of 5-FU and Oxaliplatin, the benefit from 9-ING-41 (around 20% reduction in the growth rate) did not reach statistical significance ( p = .14), but the effect of the combination was significantly better than the effect of 9-ING-41 alone ( p < .05).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.